UBS Group’s Third Harmonic Bio THRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Buy |
52,256
+4,084
| +8% | +$22.2K | ﹤0.01% | 5261 |
|
|
2025
Q1 | $167K | Buy |
48,172
+34,856
| +262% | +$121K | ﹤0.01% | 5413 |
|
|
2024
Q4 | $137K | Buy |
13,316
+2,431
| +22% | +$25K | ﹤0.01% | 5479 |
|
|
2024
Q3 | $147K | Buy |
10,885
+3,104
| +40% | +$42.1K | ﹤0.01% | 4903 |
|
|
2024
Q2 | $101K | Sell |
7,781
-11,915
| -60% | -$155K | ﹤0.01% | 5024 |
|
|
2024
Q1 | $186K | Sell |
19,696
-2,196
| -10% | -$20.7K | ﹤0.01% | 4761 |
|
|
2023
Q4 | $240K | Buy |
21,892
+11,246
| +106% | +$123K | ﹤0.01% | 4484 |
|
|
2023
Q3 | $68K | Sell |
10,646
-613
| -5% | -$3.92K | ﹤0.01% | 4970 |
|
|
2023
Q2 | $54.2K | Buy |
11,259
+7,212
| +178% | +$34.7K | ﹤0.01% | 5367 |
|
|
2023
Q1 | $16.7K | Sell |
4,047
-3,014
| -43% | -$12.4K | ﹤0.01% | 6130 |
|
|
2022
Q4 | $30.4K | Buy |
7,061
+5,809
| +464% | +$25K | ﹤0.01% | 6061 |
|
|
2022
Q3 | $24K | Buy |
+1,252
| New | +$24K | ﹤0.01% | 6067 |
|